Clinical trial NCT01882088 - References

Gastroesophageal Reflux Disease — Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD

Citation(s)

•   Burkitt DP, James PA
  Low-residue diets and hiatus hernia. Lancet. 1973 Jul 21;2(7821):128-30.
•   El-Serag HB, Satia JA, Rabeneck L
  Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut. 2005 Jan;54(1):11-7.
•   Karamanolis G, Tack J
  Nutrition and motility disorders. Best Pract Res Clin Gastroenterol. 2006;20(3):485-505. Review.
•   Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J
  Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004 Dec;53(12):1730-5.
•   Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L
  Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther. 2006 Jun 15;23(12):1725-33.
•   Terry P, Lagergren J, Ye W, Wolk A, Nyrén O
  Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology. 2001 Feb;120(2):387-91.

Phase IV Non Comparative Study of the Impact of Dietary Fiber Deficiency Correction Using Mucofalk® on Clinical Features and Motor Function of the Esophagus in Patients With Non-erosive Gastroesophageal Reflux Disease

Details for clinical trial NCT01882088